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Abstract 
 
Cancer cells have a relatively high telomerase activity compared to normal cells, so the cancer 
cells have the ability to continue to proliferate and undergo mitosis uncontrolled. Telomerase is an 
enzyme which responsible for telomere length, a DNA segment that is at the end of eukaryotic cell 
chromosomes. Telomeres and telomerase play a role in the incidence of carcinogenesis. Natural 
materials such as taro mice (Typhonium flagelliforme) have potential as anticancer. The purpose of the 
study was to determine the effects of plant extracts of rat taro on the expression of telomerase in 
cancer cell Raji. The research method is experimental studies in some form cancerous cell culture cell 
line, Raji. Used as a control normal cells is Vero cell. The Culture medium used RPMI for Raji cell  and 
M199 for Vero cell. The study consisted of three groups, control, doses of 1 ½ IC50 and IC50 doses. 
Expression of telomerase enzyme was measured by the Immunohystochemistry method (IHC). The 
results showed that the expression of telomerase in cancer cells showed values significantly higher 
than the normal cells (Vero). Giving mice taro plant extracts (Typhonium flagelliforme) were able to 
decrease the expression of telomerase significantly in both treatment doses. It was concluded that 
rodent tuber extract (Typhonium flagelliforme Lodd) can reduce the expression of telomerase in Raji 
cells, so that the rodent tuber extract (Typhonium flagelliforme Lodd) has potential as an anticancer 
through the expression of telomerase. 
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INTRODUCTION 
 
Nowadays, application of traditional medicine 
or natural material is increasing even though modern 
medicine has been advanced. Modern treatment 
costs are quite expensive and can cause side effects 
that are quite large, especially during cancer therapy, 
and the active compounds are less or not selective in 
killing cancer cells. Besides handling the tumor or 
cancer is still a lot of constraints, among others, are 
not sensitive to antiproliferative signals and able to 
avoid the apoptosis (Farida, et al., 2010, Son, et al., 
2011). One of the therapeutic concern is 
chemotherapy used bioactive materials from a 
synthesis or isolation of natural materials, one of 
them is Keladi Tikus plant (Typhonium 
flagelliforme) (Chodidjah, et al., 2014; 
Purwaningsih, et al., 2014). 
Telomere is a segment of DNA that exist at 
ends of chromosomes. It is one of the factors 
associated with the occurrence of cancer. Telomere 
length is also associated with age. Tall or short 
telomere is maintained by the telomerase enzyme 
that has specific RNA template and that is required 
to form a new telomere subunit. Telomerase activity 
in normal cells is mainly found in the reproductive 
cells because these cells have unlimited proliferative 
power. Whereas in cancer cells, telomerase activity 
is high enough (Artandi and DePinho, 2010). 
Indonesia is known as one of the countries 
with the greatest biodiversity that has potential in the 
development of herbal medicine based on medicinal 
plants in development efforts in the field of health. 
The plants produce secondary metabolites 
compounds that have activity as anticancer such as 
alkaloids, terpenoids and flavonoids. One of the 
plants that contain potential compounds as an 
anticancer is Keladi Tikus plant (Typhonium 
flagelliforme Lodd) (Hariana, 2013). 
The chemical content of Keladi Tikus plant 
has not been known. Phytochemical analysis results 
at the Research Institute of Medicinal and Aromatic 
Plants show that it contains alkaloids, saponins, 
steroids and glycosides, yet unknown active 
compound that specific to the Keladi Tikus plant that 
plays a role in curing cancer (Syahid and Kristina, 
2007).  
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Extracts of sodium chloride Keladi Tikus 
leaves contain Ribosome Inactivating Protein (RIPs). 
Rips is a protein with an activity which able to cut 
the DNA or RNA of cancer cells thereby impacting 
in disable the growth of cancer cells without 
damaging surrounding tissue. In addition RIPs can 
also block the growth of cancer cells. (Syahid and 
Kristina, 2007; de Virgilio, 2010). 
Considering the Keladi Tikus plant has 
potential as an anticancer and in general cancer cells 
showed high telomerase expression, then we want to 
know the potential Keladi Tikus plant extract on the 
expression of the telomerase enzyme in cancer cells. 
The research objective was to determine the 
expression of telomerase in cancer cell cultures Raji 
after being given Keladi Tikus plant extract 
(Typhonium flagelliforme Lodd).  
 
METHODS 
 
Research Design 
This study was an experimental laboratory 
research with a case-control study design, consisted 
of two groups: Raji cells group and control group of 
normal cells (Vero). Each group consisted of three 
dose groups (control, dose 1 ½ IC50 and IC50). 
 
Research Subject 
The experimental subjects were Raji cancer 
cell cultures (cell line) and normal cells (Vero) 
obtained from Parasitology Laboratory, Faculty of 
Medical, UGM. Cells were cultured in 24-wells 
microplate using RPMI medium (Rosewell Park 
Memorial Institute), each group performed in two 
replications. Cell cultures were incubated for 72 
hours or until the cultures were confluent which had 
a density of 1x10
4
 cells/wells. After the cultures 
were confluent, then the treatment performed in 
appropriately prescribed doses. 
 
Herbs/Plants Material 
Keladi tikus (Typhonium flagelliforme) was 
obtained from the medical plants garden in 
Jagakarsa, South Jakarta. 
 
Production of Medium for Cells Culture and 
Growth 
The cell culture medium was prepared by 
dissolving one sachet of powder RPMI and M199 
into 800 mL of aquabidest approximately, then 2.0 
grams sodium bicarbonate and 2.0 grams HEPES 
was added, at the last aquabidest was added up to 
one liter of solution. The solution was stirred for 
about 10 minutes with a magnetic stirrer until it was 
homogeneous. After that, the homogenuos solution 
was neutralized by adding 1 N HCl to obtain pH at 
7.2 to 7.4. 
The growth cells medium prepared by mixing 
FBS as much as 19 mL, 2 mL penicillin-
streptomycin, and 0.5 mL Fungizone, then diluted in 
culture medium up to 100 mL. Furthermore, the 
solution is filtered with 0.2 μm sterile polyethylene 
sulfone filter aseptically. The medium was stored in 
the refrigerator by using a sealed bottle. 
 
Preparation of Keladi Tikus Extract 
Keladi tikus extract (from the whole plant) 
was made by this way: all the fresh plants was 
washed and sliced thinly then it was dried. After 
that, the chopped was powdered. The powder was 
macerated with 80% ethanol in erlenmeyer while 
doing a continous shuffling. The ethanol extract then 
was transferred into rotary flask and concentrated 
using rotary evaporator. Concentrated extract of 
keladi tikus was dissolved in DMSO, then it diluted 
to  obtain  a  series  of  concentrations  and  filtered 
with 0.2 μm filter before it was put into 24-wells 
plate. 
 
Examination of the Telomerase Expression 
through Immunohystochemistry Method/IHC 
HeLa cells culture, T47D and Vero with 
density 10
4 
cells/well plate that have been stuck on 
coverslip conducted immunochemistry staining 
(IHC) in Parasitology laboratory Faculty of 
Medicine, UGM. The procedure of telomerase 
expression observation  through IHC as the 
following : 
Cells culture on the coverslip that has been given 
treatment and incubated in incubator 5 % CO2 at 
37
o
C for 24 hours was taken and put on the object 
glass ((poly-l-lysine slide), fixate by aceton or 
methanol for 10 minutes at -20
0
C, then washed with 
PBS 3 times, 5 minutes and given some drops of 
norma lmouse serum (1:50) for 15 minutes and 
dispose the liquid (without washed). Then the object 
glass was given same drops of primer antibody 
(telomerase) for 60 minutes. Washed in PBS 3 times, 
each for 5 minutes, then incubate in the biotin 
secondary antibody (biotinylated secondary 
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antibody) for 5–10 minutes, washed with PBS 3 
times, each for 5 minutes. Incubate in streptavidin-
proxyde enzyme for 5-10 minutes, washed with PBS 
3 times, each for 5 minutes. Incubate in Kromogen 
deaminobenzidin tetrahidroklorid (DAB) for 10-15 
minutes with comparison substrate chromogen 1 : 
20, then washed with aquadest. Preparation was 
soaked in hematoksilin for 3-5 minutes for 
counterstain, wash with aquadest and dehydrate 
using ethanol 95%, then with xylen each for 10 
minutes. Then, preparation was given some drops of 
mounting media (Canada balsem) and covered using 
cover glass. Telomerase expression was observed 
using light microscope. Cell that expressing 
telomerase will give brown color, while cell that 
doesn’t express telomerase will give purplish blue 
color. 
 
Data Analysis 
Data analyzed use statistical Anova test 
followed by multiple comparison test with SPSS 18 
version. 
 
RESULT AND DISCUSION 
 
Before IHC assay performed to telomerase 
expression, cytotoxicity assay was performed and 
gotten IC50 score 53.799 µg/mL. Telomerase 
expression observation by IHC method was 
performed by calculate the amount of cell that shows 
positive expression (brown color) from 100 cells 
were examined. The result was represented in 
percent. This study uses cancer cells in cell line and 
normal cells as control that is Vero normal cell and 
lymphoma cancer cells, Raji cells. Percentage score 
of positive telomerase expression of the three groups 
with eatch treatment dosage   showed in Tabel 1. 
Telomerase expression on Raji cancer cells showed 
higher expression than on normal cells (Vero). From 
statistical analysis using ANOVA, there was lower 
expression of telomerase on Raji cell group than 
control group (Vero) after being treated with keladi 
tikus extract. Statistical analysis using LSD of 
telomerase expression of each group was performed 
in Table 2.  
 
  
Table 1. Expression of telomerase on control group and case group 
 
Replication 
Vero (control) Raji 
K 1/2IC IC K 1/2IC IC 
1 5 0 0 67 23 9 
2 3 1 0 67 23 12 
3 3 1 0 67 22 12 
Mean 3.667 0.667 0 67 22.667 11 
SD 1.155 0.577 0.000 0.000 0.577 1.732 
 
 
Table 2. Least Significant Different of positive telomerase expression of each group 
 
Group Vero K Vero ½ 
IC50 
Vero 1 
IC50 
Raji 
K 
Raji 
½ IC50 
Raji 
1 IC50 
Vero K 
 
- - - ** ** ** 
Vero ½ IC50 - - - ** ** ** 
Vero1 IC50 - - - ** ** ** 
Raji Kontrol ** ** ** - - - 
Raji ½ IC 50 ** ** ** - - - 
Raji 1 IC 50 ** ** ** ** - - 
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Telomerase is ribonucleoprotein which has a 
function to maintain the protection structure on the 
end of chromosome called telomere. Telomerase has 
responsibility telomere maintenance, a replicated 
nucleotide (TTAGGG) n. In somatic cells like 
fibroblast, telomerase expression is reduced and 
telomere would progressively shorter in every cell 
division. Otherwise, tumor cells or cancer cells in 
human steadily express telomerase. Maintenance of 
telomerase become very important on tumor or 
cancer cells. Telomerase activity determines the cell 
proliferation of tumor or cancer cells in vivo or in 
vitro condition (Quelette, et al., 2011). In normal 
cells like fibroblast, telomerase activity like hTERT 
(human telomerase reverse transcriptase) and 
telomere length determine the aging process. 
Interference of telomerase activity on normal cells 
would slow down cell proliferation, limit cell age, 
and change maintenance of three single stands 
telomeric overhang without affecting telomere 
shortening. There is a difference of telomere activity 
between normal stem cells and cancer stem cells 
(Masutomi, et al., 2003; Shay and Wright, 2011). 
Raji cell using in this study is cell line culture 
of lymphoblastoid derived from lymphoma Burkitt 
(BL), which has high expression of BAFF (B cell 
activating factor belonging to TNF family). 
Inhibition of BAFF and its receptor would inhibit 
telomerase expression on Raji cells (Zhang, et al., 
2011). 
In this study, telomerase expression 
(appearance by TERF-2 concentration) in lymphoma 
cancer cells (Raji cells) was significantly higher than 
the concentration TERF-2 on normal Vero cells 
(fibroblasts). Researchers have previously reported, 
that cancer cells generally have high telomerase 
activity compared to normal cells (Artandi & 
DePinho, 2010), such as a non-Hodgkin lymphoma 
cell (Ely, et al., 2000). Telomerase activity in 
lymphoma cell is varied and show characteristics in 
different types of B-cell non-Hodgkin lymphoma (B-
NHL). 
Other studies have linked the expression of 
telomerase in cancer cells has been done by previous 
researchers in HeLa cells using triethylene tetraamin 
(TETA) using modified telomeric repeat 
amplification (TRAP) and flowsitometri method. It 
was reported that triethylene tetraamin (TETA) in 
micromolar concentrations can inhibit the 
proliferation of HeLa cells at the G1 phase. 
Telomerase activity in HeLa cells and T47D cells is 
quite high and the cells rapidly divide or high 
proliferation rate. This raises a thought their 
telomerase inhibitor that acts as a cancer therapy, 
through the molecular mechanism (Ivankovic, et al., 
2007, Nasiri, et al., 2013). 
Research in vivo were performed in patients 
with colon cancer, also reported the expression of 
telomerase subunit hTERT (human telomerase 
reverse transcriptase), HTR (human telomerase 
RNA), and TP1 (TEP1) (telomerase-associated 
protein1) in colon cancer cells was higher than the 
expression of telomerase in normal cells. Therefore, 
telomerase could be a marker that is good enough for 
the incidence of cancer (Nowak, et al., 2003). 
In addition telomerase activity in pancreatic 
cancer cells also showed a high expression compared 
with normal cells. Telomerase activity examined in 
both specimens pancreatic cancer and metastatic 
lesions. The result showed telomerase activity in 
cancer cells with metastatic lesions was higher than 
primary tumor cells. Lower telomerase activity was 
found in non-malignant pancreatic cell disorders 
such as benign, acute and chronic adenomas (Zizuh 
and Hans, 2012). 
Provision of keladi tikus extract can lower the 
expression of telomerase in cancer cells, Rajibaik at 
doses ½ IC50 and 1 IC50 dose. This suggests that 
agents/compounds in keladi tikus extracts have a 
potential as an agent/anticancer compounds on Raji 
cells or lymphoma cell. The previous research is 
reported that there are four active fraction contained 
in keladi tikus that is pheophorbide-a, pheophorbide-
a', and pyropheophorbid pyropheophorbide-a-a'. 
Other compounds which have also been identified is 
oleic acid, linoleic acid, stigmasterol and beta 
sitosterol. (Lai, et al., 2010). In this case alleged, that 
the factions can lowering the expression of 
telomerase in Raji cells. 
The short telomeres in cancer stem cells may 
reﬂect the multistep nature of cancer initiation 
against drugs or antineoplastic. In some culture of 
tumor cells, telomerase activity is decreased after 
treatment with antineoplastic drugs (Sakin, et al., 
2008). Typhonium flagelliforme extract also 
decreased the expression of telomerase in Raji cells. 
A previous study report that Typhonium 
flagelliforme extract decrease the expression of 
telomerase in cells MCF -7 and Widr at different 
doses (Purwaningsih, et al., 2014b). 
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The subline MCF is reported resistant to 
doxorubicin and vincristine. The resistances of these 
drugs are not directly related to the level of 
expression of hTERT and telomerase activity levels 
(Sakin, et al., 2008). Other studies have reported that 
T47D cells also have high telomerase activity. 
Provision of curcumin and silibinin can inhibit the 
growth or proliferation of T47D cells and decrease 
the expression of genes hTERT (human telomerase 
Reverse Transcriptase) (Nasiri, et al., 2013). 
 
CONCLUSION 
 
The Typhonium flagelliforme extract can 
reduce the expression of telomerase in Raji cells. It 
indicates a potent chemoprevention of the extract 
against the expression of telomerase.  
 
SUGGESTION 
 
Further research is needed to determine the 
effect of Typhonium flagelliforme extract to the 
length of telomere nucleotides that plays a role in the 
incidence of cancer. 
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